| Primary |
| Drug Use For Unknown Indication |
35.6% |
| Hypertension |
21.1% |
| Pre-eclampsia |
10.1% |
| Immunosuppression |
4.9% |
| Tocolysis |
4.0% |
| Infection |
2.8% |
| Pyrexia |
2.8% |
| Constipation |
2.4% |
| Hiv Infection |
2.0% |
| Blood Pressure |
1.6% |
| Blood Pressure Increased |
1.6% |
| Depression |
1.6% |
| Ischaemic Cardiomyopathy |
1.6% |
| Threatened Labour |
1.6% |
| Blood Pressure Management |
1.2% |
| Hyperthermia Malignant |
1.2% |
| Nephroblastoma |
1.2% |
| Anaesthesia |
0.8% |
| Cervix Disorder |
0.8% |
| Hypotension |
0.8% |
|
| Respiratory Distress |
9.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
7.9% |
| Premature Baby |
7.9% |
| Premature Labour |
7.9% |
| Death |
6.3% |
| Intra-uterine Death |
6.3% |
| Drug Exposure During Pregnancy |
4.8% |
| Mitral Valve Incompetence |
4.8% |
| Pancreatitis |
4.8% |
| Patent Ductus Arteriosus |
4.8% |
| Platelet Count Decreased |
4.8% |
| Purpura |
4.8% |
| Acute Pulmonary Oedema |
3.2% |
| Drug Interaction |
3.2% |
| Extravasation |
3.2% |
| Hypotension |
3.2% |
| Ileus |
3.2% |
| Labour Onset Delayed |
3.2% |
| Neonatal Respiratory Distress Syndrome |
3.2% |
| Pericardial Effusion |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.9% |
| Ill-defined Disorder |
16.7% |
| Hypertension |
13.0% |
| Product Used For Unknown Indication |
11.5% |
| Sedation |
6.8% |
| Anaesthesia |
4.6% |
| Antibiotic Therapy |
3.3% |
| Antibiotic Level |
2.7% |
| Drug Exposure During Pregnancy |
2.1% |
| Polyuria |
2.1% |
| Premedication |
1.9% |
| Diabetes Mellitus |
1.8% |
| Pyrexia |
1.8% |
| Vitamin Supplementation |
1.8% |
| Constipation |
1.6% |
| Infection |
1.6% |
| Tocolysis |
1.6% |
| Hypotension |
1.5% |
| Muscle Relaxant Therapy |
1.5% |
| Blood Pressure Management |
1.3% |
|
| Toxic Epidermal Necrolysis |
17.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
12.3% |
| Fall |
9.6% |
| Renal Failure Acute |
6.8% |
| Cerebral Infarction |
5.5% |
| Disorientation |
4.1% |
| Hypoglycaemia Neonatal |
4.1% |
| Pleural Effusion |
4.1% |
| Unresponsive To Stimuli |
4.1% |
| Wrist Fracture |
4.1% |
| Aspartate Aminotransferase Increased |
2.7% |
| Cytolytic Hepatitis |
2.7% |
| Eczema |
2.7% |
| Hypoglycaemia |
2.7% |
| Orthostatic Hypotension |
2.7% |
| Pruritus |
2.7% |
| Rash Maculo-papular |
2.7% |
| Surgery |
2.7% |
| Thrombocythaemia |
2.7% |
| Thrombocytopenic Purpura |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.7% |
| Drug Use For Unknown Indication |
25.4% |
| Hypertension |
10.5% |
| Prophylaxis |
5.1% |
| Acute Myeloid Leukaemia |
2.9% |
| Infection Prophylaxis |
2.6% |
| Multiple Myeloma |
2.1% |
| Hiv Infection |
1.7% |
| Pain |
1.7% |
| Diabetes Mellitus |
1.7% |
| Bone Marrow Conditioning Regimen |
1.2% |
| Premedication |
1.2% |
| Prophylaxis Against Graft Versus Host Disease |
1.2% |
| Anxiety |
1.1% |
| Thrombosis Prophylaxis |
0.9% |
| Sedation |
0.8% |
| Atrial Fibrillation |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Anaesthesia |
0.8% |
| Rheumatoid Arthritis |
0.8% |
|
| Rhabdomyolysis |
9.0% |
| Vomiting |
7.8% |
| Cardiac Arrest |
7.2% |
| Respiratory Failure |
6.6% |
| Renal Failure |
6.0% |
| Renal Failure Acute |
5.4% |
| Tachycardia |
5.4% |
| Pulmonary Oedema |
4.8% |
| Wound Drainage |
4.8% |
| Multi-organ Failure |
4.2% |
| Platelet Count Decreased |
4.2% |
| Pneumonia Aspiration |
4.2% |
| Thrombocytopenia |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Death |
3.6% |
| Endocarditis |
3.6% |
| Pyrexia |
3.6% |
| Thrombocytopenic Purpura |
3.6% |
| Thrombosis |
3.6% |
|
| Interacting |
| Immunosuppression |
56.3% |
| Hypertension |
37.5% |
| Trigeminal Neuralgia |
6.3% |
|
| Drug Interaction |
40.0% |
| Unresponsive To Stimuli |
20.0% |
| Drug Level Changed |
10.0% |
| Kidney Transplant Rejection |
10.0% |
| Transplant Rejection |
10.0% |
| Urine Output Decreased |
10.0% |
|
